http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021218948-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_27fade90728c3023697f458de968333c |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-13 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04 |
| filingDate | 2021-04-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_feefd5cef413844f78ddeaecbf283c74 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a25246ff0e582858382e8c055e2dfaaa http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f41a71ddf2edc0a0e48f0dfe65c05c96 |
| publicationDate | 2021-11-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | WO-2021218948-A1 |
| titleOfInvention | Crystal forms of sulfonamide compound and preparation method therefor |
| abstract | The present invention relates to crystal forms of a sulfonamide compound and a preparation method therefor. Provided in the present invention are five crystal forms B, C, D, E and F of a compound of formula (I), and a preparation method therefor and the use thereof. Also provided in the present invention is a method for preparing crystal form A. The crystal forms B, C, D, E and F of the compound of formula (I) provided in the present invention have advantages in at least one of solubility, melting point, stability, dissolution, hygroscopicity, adhesion, fluidity, biological effectiveness, processing performance, purification effect, preparation production, safety and so on, and provide a new and better choice for the preparation of a pharmaceutical preparation containing the compound of formula (I), which has very important implications for drug development. |
| priorityDate | 2020-04-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 26.